125 Application of Kojic Acid in Treatment of Melasma (5) Oliveira RVM, Ohara MT, Gonçalves MM, Vila MMDC. Quantificação do Ácido Kójico em Estudos de Permeação in Vivo. Lat Am J Pharm. 2007 26(4):576–581. Accessed March 6, 2023. https://docplayer. com.br/72141559-Quantificacao-de-acido-kojico-em-estudos-de-permeacao-in-vitro.html. (6) Saeedi M, Eslamifar M, Khezri K. Kojic acid applications in cosmetic and pharmaceutical preparations. Biomed Pharmacother. 2019 110:582–593. Accessed March 1, 2023. DOI: 10.1016/j.biopha.2018.12.006. (7) Zachary CM, Wang JV, Saedi N. Kojic acid for felasma: Popular ingredient in skincare products. Skinmed. 2020 1(18):271–273. Accessed March 6, 2023. https://pubmed.ncbi.nlm.nih.gov/33160435/. (8) The Joanna Briggs Institute. Joanna Briggs Institute Reviewers’ Manual 2015: Methodology for JBI Scoping Reviews. The Joanna Briggs Institute 2015. Accessed March 6, 2023. https://repositorio.usp.br/ item/002775594. (9) Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med. 2018 169(7):467–473. Accessed March 1, 2023. DOI: 10.7326/M18-0850. (10) Rayyan. Accessed March 1, 2023. https://rayyan.ai/users/sign_in. (11) Sardesai VR, Kolte JN, Srinivas BN. A clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment. Indian J Dermatol. 2013 58(3):239. Accessed March 1, 2023. DOI: 10.4103/0019-5154.110842. (12) Monteiro RC, Kishore N, Bhat RM, Sukumar D, Martis J, Ganesh K. A comparative study of the efficacy of 4% hydroquinone vs 0.75% kojic acid cream in the treatment of facial melasma. Indian J Dermatol. 2013 58(2):157. Accessed March 1, 2023. DOI: 10.4103/0019-5154.108070. (13) Cameli N, Abril E, Mariano M, Berardesca E. Combined use of monopolar radiofrequency and transdermal drug delivery in the treatment of melasma. Dermatol Surg. 2014 40(7):748–755. Accessed March 1, 2023. DOI: 10.1111/dsu.0000000000000029. (14) Yenny SW. Comparison of the use of 5% methimazole cream with 4% kojic acid in melasma treatment. Turk J Dermatol. 2018 12(4):167–171. Accessed March 1, 2023. DOI: 10.4274/tdd.3640. (15) Iraji F, Asililan A, Fadaei F, Nilforoushzadeh MA. Comparing kojic acid cream 2% with glycolic acid 10% and hydroquinone cream 2% in treatment of melasma. J Isfahan Med Sch. 2014 31(269):2295–2300. www.mui.ac.ir. Accessed March 6. 2023. https://jims.mui.ac.ir/article_14238.html?lang=en. (16) Sheikh M, Majeed R, Iqbal W. Comparing the effectiveness of oral formulation of tranexamic acid in treating melasma versus topical treatment like kojic acid. Pakistan J Med Health Sci. 2021 15(6):1372–1375. Accessed March 1, 2023. DOI: 10.53350/pjmhs211561372. (17) Mesquita-Guimarães J, Baudrier MT, Mota A, et al. Depigmentation cream D4® in the treatment of melasma. Med Cutan Iber Lat Am. 2005 33(1):19–24. Accessed March 6. 2023. https://www.medigraphic. com/pdfs/cutanea/mc-2005/mc051c.pdff. (18) Azzam OA, Leheta TM, Nagui NA, Shaarawy E, Abdel Hay RMA, Hilal RF. Different therapeutic modalities for treatment of melasma. J Cosmet Dermatol. 2009 8(4):275–281. Accessed March 1, 2023. DOI: 10.1111/j.1473-2165.2009.00471.x. (19) Costa A, de Arruda LHF, Pereira ESP, de Oliveira Pereira M, dos Santos FBC, Fávaro R. Evaluation of the whitening properties of combined kojic acid, arbutin, sepiwhite® and achromaxyl® vs. 2% and 4% hydroquinone in the treatment of melasma. Surg Cosmet Derm. 2012 3(4):22–30. Accessed March 9, 2023. http://www.redalyc.org/articulo.oa?id=265523678005. (20) Berardesca E, Rigoni C, Cantù A, Cameli N, Tedeschi A, Laureti T. Effectiveness of a new cosmetic treatment for melasma. J Cosmet Dermatol. 2020 19(7):1684–1690. Accessed March 1, 2023. DOI: 10.1111/jocd.13203. (21) Bhagwat PV, Manangi S, Dani A, Kudligi C. Efficacy and safety of 2% kojic acid containing formulation versus modified Kligman’s formula in melasma—a comparative study. J Pak Assoc Dermatol. 2016 26(3):183–187. Accessed March 9, 2023. https://www.jpad.com.pk/index.php/jpad/article/view/19/6. (22) Chowdhury WK, Wahab MA, Anwar MH, Khan MSI. Efficacy and safety of hydroquinone, kojic acid and glycolic acid combination in the treatment of melasma. Bangladesh J Med Sci. 2012 11(03):1–7. Accessed March 9, 2023. https://www.banglajol.info/index.php/BJMS/article/view/11720. (23) Fragoso-Covarrubias CE, Tirado-Sánchez A, Ponce-Olivera RM. Efficacy and safety of the combination of arbutin 5%+glycolic acid 10%+kojic acid 2% versus hydroquinone 4% cream in the management of facial melasma in Mexican women with Fitzpatrick skin type III-IV. Dermatol Rev Mex. 2015 59(4):263–270.

126 JOURNAL OF COSMETIC SCIENCE Accessed March 9, 2023. https://www.researchgate.net/publication/282284632_Efficacy_and_safety_ of_the_combination_of_arbutin_5_glycolic_acid_10_kojic_acid_2_versus_hydroquinone_4_cream_ in_the_management_of_facial_melasma_in_Mexican_women_with_Fitzpatrick_skin_type_III-IV. (24) Tsilika K, Levy JL, Kang HY, et al. American Society for Laser Medicine and Surgery Abstracts. Lasers Surg Med. 2011 985(985):907–1018. Accessed March 9, 2023. DOI: 10.1002/lsm.21034. (25) Xing X, Chen L, Xu Z, Jin S, Zhang C, Xiang L. Efficacy of a topical agent containing tranexamic acid, niacinamide and kojic acid in melasma. J Clin Cosmet Derm. 2021 5(2):1–4. Accessed March 1, 2023. DOI: 10.16966/2576-2826.160. (26) Draelos ZD, Yatskayer M, Bhushan P, Pillai S, Oresajo C. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening. Cutis. 2010 86:153–158. Accessed March 9, 2023. https://pubmed.ncbi.nlm.nih.gov/21049734/. (27) Deo KS, Dash KN, Sharma YK, Virmani NC, Oberai C. Kojic acid vis-a-vis its combinations with hydroquinone and betamethasone valerate in melasma: A randomized, single blind, comparative study of efficacy and safety. Indian J Dermatol. 2013 58(4):281. Accessed March 1, 2023. DOI: 10.4103/0019-5154.113940. (28) Arunnair V, Kumaraswamy G, Ramesh M. Pattern of drug utilisation in the management of hyperpigmentary disorders in a tertiary care hospital—an observational study. J Clin Diagnostic Res. 2021 15(10):FC01–FC06. Accessed March 1, 2023. DOI: 10.7860/JCDR/2021/44461.15532. (29) Garcia A, Fulton JE. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatologic Surgery. 1996 22(5):443–447. Accessed March 1, 2023. DOI: 10.1111/j.1524-4725.1996.tb00345.x. (30) Srivastava R, John AM, Tam A, Firoz BF. The Tam formula: A pilot study for a new treatment for melasma. J Cosmet Dermatol. 2021 20(7):2168–2171. Accessed March 1, 2023. DOI: 10.1111/jocd.13849. (31) Cotellessa C, Peris K, Onorati MT, Fargnoli MC, Chimenti S. The use of chemical peelings in the treatment of different cutaneous hyperpigmentations. Dermatol Surg. 1999 25:450–454. Accessed March 1, 2023. DOI: 10.1046/j.1524-4725.1999.08217.x. (32) Lim TJ. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg. 1999 25:282–284. Accessed March 1, 2023. DOI 10.1046/j.1524-4725.1999.08236.x. (33) Wali V, Patil S, Patil SK, Hogade AS, Manthale NS, Sagare PS. Comparative efficacy of Kligman’s regimen over other topical therapies in treatment of melasma. J Evol Med Dent Sci. 2013 2(51):9856–9868. Accessed March 1, 2023. https://go.gale.com/ps/i.do?p=AONE&sw=w&issn= 22784748&v=2.1&it=r&id=GALE%7CA362849847&sid=googleScholar&linkaccess=fulltext. (34) Silva JN. Produção de Ácido Kójico Através Da Fermentação Do Arroz. 2011. Accessed March 1, 2023. https:// cepein.femanet.com.br/BDigital/arqTccs/0711290181.pdf. (35) Handel AC, Miot LDB, Miot HA. Melasma: A clinical and epidemiological review. An Bras Dermatol. 2014 89(5):771–782. Accessed March 1, 2023. DOI: 10.1590/abd1806-4841.20143063. (36) Traikovich SS. Use of topical ascorbic acid and its effects on photodamaged skin topography. Arch Otolaryngol Head Neck Surg. 1999 125:1091–1098. Accessed March 1, 2023. http://archotol.jamanetwork. com/. (37) Narda M, Trullas C, Brown A, Piquero-Casals J, Granger C, Fabbrocini G. Glycolic acid adjusted to pH 4 stimulates collagen production and epidermal renewal without affecting levels of proinflammatory TNF-alpha in human skin explants. J Cosmet Dermatol. 2021 20(2):513–521. Accessed March 1, 2023. DOI: 10.1111/jocd.13570. (38) Saeedi M, Eslamifar M, Khezri K. Kojic acid applications in cosmetic and pharmaceutical preparations. Biomed Pharmacother. 2019 110(November 2018):582–593. Accessed March 1, 2023. DOI: 10.1016/j. biopha.2018.12.006 (39) González-Molina V, Martí-Pineda A, González N. Topical treatments for melasma and their mechanism of action. J Clin Aesthet Dermatol. 2022 15(5):19–28. Accessed March 1, 2023. https://www.ncbi.nlm.nih. gov/pmc/articles/PMC9122278/.